LakeShore Biopharma Co Ltd (LSB)

Currency in USD
0.6939
+0.0113(+1.66%)
Real-time Data·
LSB Scorecard
Full Analysis
Net income is expected to grow this year
LSB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.65000.7000
52 wk Range
0.59008.6000
Key Statistics
Prev. Close
0.6826
Open
0.669
Day's Range
0.65-0.7
52 wk Range
0.59-8.6
Volume
19.23K
Average Volume (3m)
299.29K
1-Year Change
-83.06%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LSB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

LakeShore Biopharma Co Ltd Company Profile

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.

Employees
573

Compare LSB to Peers and Sector

Metrics to compare
LSB
Peers
Sector
Relationship
P/E Ratio
−2.0x−15.0x−0.5x
PEG Ratio
−0.02−0.130.00
Price/Book
-5.3x2.6x
Price / LTM Sales
0.3x22.6x3.3x
Upside (Analyst Target)
-147.4%43.4%
Fair Value Upside
Unlock−8.4%7.1%Unlock

Earnings

Latest Release
Aug 15, 2024
EPS / Forecast
-12.20 / -0.69
Revenue / Forecast
135.35M / 163.84M
EPS Revisions
Last 90 days

LSB Income Statement

People Also Watch

51.38
BMNR
+24.47%
5.205
GVH
+0.87%
5.16
REPL
-5.84%
11.9300
INKT
-5.77%

FAQ

What Stock Exchange Does LakeShore Biopharma Trade On?

LakeShore Biopharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LakeShore Biopharma?

The stock symbol for LakeShore Biopharma is "LSB."

What Is the LakeShore Biopharma Market Cap?

As of today, LakeShore Biopharma market cap is 28.13M.

What Is LakeShore Biopharma's Earnings Per Share (TTM)?

The LakeShore Biopharma EPS (TTM) is -5.22.

From a Technical Analysis Perspective, Is LSB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has LakeShore Biopharma Stock Split?

LakeShore Biopharma has split 2 times.

How Many Employees Does LakeShore Biopharma Have?

LakeShore Biopharma has 573 employees.

What is the current trading status of LakeShore Biopharma (LSB)?

As of 08 Aug 2025, LakeShore Biopharma (LSB) is trading at a price of 0.69, with a previous close of 0.68. The stock has fluctuated within a day range of 0.65 to 0.70, while its 52-week range spans from 0.59 to 8.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.